July 2019 summary of P&R decisions in Spain is now available for downloading
The July 2019 summary of P&R decisions from the Spanish Interministerial Med [...]
Horizon 2022 Event organised by ECO Foundation
Omakase is proud of participating in the upcoming event on Monday 16th organised [...]
Executive Summary of the updated version of “Omakase Lab 1 2018 – P&R Orphan Drugs (2012-2016)
Omakase is delighted to share with you the Executive Summary of the updated vers [...]
The June 2019 Summary of P&R decisions from the Spanish Interministerial Medicinal Products Pricing Committee (CIPM) is now translated and available to download in English.
As you will see, there is only one medicinal product with P&R refusal, and a [...]
The latest and newest version of P&R decisions from the Spanish Interministerial Medicinal Products Pricing Committee (CIPM) is now translated and available to download in English
The latest and newest version of P&R decisions from the Spanish Interministe [...]
The Interministerial Medicinal Product Pricing Committee (CIPM) continues to increase the transparency of its decisions
The Interministerial Medicinal Product Pricing Committee (CIPM) continues to inc [...]
April 25th 2019 Summary of P&R decisions in Spain is now available for downloading
INCREASED TRANSPARENCY IN P&R DECISIONS IN SPAIN From now on, the Spanish In [...]
March 18th 2019 Summary of P&R decisions in Spain is now available for downloading
It is a pleasure to share the latest Summary of P&R decisions where you can [...]
The March 2019 Summary of Therapeutic Positioning Reports is now available for downloading
The March 2019 Summary of Therapeutic Positioning Reports from the Spanish Medic [...]